ContraFect Corporation to Present at the 13th Annual BIO Investor Forum
30 sept. 2014 07h30 HE
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Sep 30, 2014) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company focused on the discovery and development of protein...
ContraFect Corporation Expands Senior Management Team
24 sept. 2014 07h30 HE
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Sep 24, 2014) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company focused on the discovery and development of protein...
ContraFect Corporation to Present at BioCentury's 21st Annual NewsMakers in the Biotech Industry Conference
19 sept. 2014 07h30 HE
|
ContraFect Corporation
YONKERS, NEW YORK--(Marketwired - Sep 19, 2014) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company focused on protein and antibody therapeutic products...
ContraFect Corporation's Universal Influenza Treatment Receives SBIR Funding
16 sept. 2014 07h30 HE
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Sep 16, 2014) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company focused on the discovery and development of protein...
ContraFect Corporation Announces Separation of Units Sold in IPO
09 sept. 2014 07h30 HE
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Sep 9, 2014) - ContraFect Corporation (NASDAQ: CFRXU), a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious...
ContraFect Corporation to Present at the Rodman & Renshaw 16th Annual Healthcare Conference
03 sept. 2014 07h30 HE
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Sep 3, 2014) - ContraFect Corporation (NASDAQ: CFRXU), a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious...
ContraFect Corporation Showcases CF-301 at ICAAC 2014 Meeting in Washington, D.C.
02 sept. 2014 17h00 HE
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Sep 2, 2014) - ContraFect Corporation (NASDAQ: CFRXU), a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious...
ContraFect Corporation Announces Exercise of Initial Public Offering Over-Allotment Option
27 août 2014 17h00 HE
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Aug 27, 2014) - ContraFect Corporation (NASDAQ: CFRXU), a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious...
ContraFect Corporation Announces Closing of Initial Public Offering
04 août 2014 07h30 HE
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Aug 4, 2014) - ContraFect Corporation (NASDAQ: CFRXU), a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious...
ContraFect Announces Pricing of Its Initial Public Offering
29 juil. 2014 07h30 HE
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Jul 29, 2014) - ContraFect Corporation (NASDAQ: CFRXU), a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious...